Philadelphia 76ers · — · #—
—
| Period | GP | MIN | PTS | REB | AST | PRA | STL | BLK | TOV | 2PM | 2PA | 2P% | 3PM | 3PA | 3P% | FTM | FTA | FT% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Last 3 | 3 | 17.2 | 3.0 | 3.3 | 0.3 | 6.7 | 0.3 | 0.0 | 1.0 | 1.0 | 2.3 |
| 42.9% |
| 0.0 |
| 0.0 |
| 0.0% |
| 1.0 |
| 1.3 |
| 75.0% |
| Last 5 | 5 | 16.2 | 4.2 | 3.0 | 0.6 | 7.8 | 0.2 | 0.0 | 1.0 | 1.8 | 2.8 | 64.3% | 0.0 | 0.0 | 0.0% | 0.6 | 0.8 | 75.0% |
| Last 10 | 10 | 16.3 | 4.5 | 3.5 | 0.7 | 8.7 | 0.4 | 0.6 | 0.8 | 1.7 | 2.5 | 68.0% | 0.0 | 0.0 | 0.0% | 1.1 | 1.5 | 73.3% |
| Last 20 | 20 | 19.6 | 6.0 | 4.8 | 0.8 | 11.6 | 0.6 | 0.8 | 0.9 | 2.4 | 4.0 | 58.8% | 0.0 | 0.1 | 0.0% | 1.3 | 1.7 | 76.5% |
| Season | 71 | 17.4 | 4.8 | 4.3 | 0.5 | 9.6 | 0.4 | 1.2 | 0.8 | 1.8 | 3.0 | 60.3% | 0.0 | 0.1 | 33.3% | 1.1 | 1.6 | 70.8% |
high offensive rebounding, high rim finishing off the ball, high contested shots per minute, low off-ball shooting
2025-26 season · fitted over 2022-23–2025-26
Style profile over 446 qualified players (8+ games, 10+ min/game). 100% is an identical profile; 50% is unrelated.
| Date | Matchup | W/L | MIN | PTS | REB | AST | STL | BLK | TOV | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-12 | PHI vs. MIL | W | 17.1 | 4 | 2 | 0 | 0 | 0 | 0 | 2 | 3 | 66.7% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 10.0 |
| 2026-04-10 | PHI @ IND | W | 19.4 | 3 | 6 | 1 | 1 | 0 | 1 | 1 | 3 | 33.3% | 0 | 0 | 0.0% | 1 | 2 | 50.0% | -13.0 |
| 2026-04-09 | PHI @ HOU | L | 15.0 | 2 | 2 | 0 | 0 | 0 | 2 | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | -9.0 |
| 2026-04-04 | PHI vs. DET | L | 23.1 | 10 | 4 | 2 | 0 | 0 | 1 | 5 | 5 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -2.0 |
| 2026-04-03 | PHI vs. MIN | W | 6.2 | 2 | 1 | 0 | 0 | 0 | 1 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -5.0 |
| 2026-04-01 | PHI @ WAS | W | 21.2 | 13 | 4 | 1 | 2 | 1 | 0 | 5 | 5 | 100.0% | 0 | 0 | 0.0% | 3 | 3 | 100.0% | 23.0 |
| 2026-03-30 | PHI @ MIA | L | 14.4 | 2 | 3 | 0 | 0 | 1 | 0 | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 10.0 |
| 2026-03-28 | PHI @ CHA | W | 5.9 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -4.0 |
| 2026-03-25 | PHI vs. CHI | W | 14.7 | 4 | 8 | 0 | 0 | 2 | 2 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | -2.0 |
| 2026-03-23 | PHI vs. OKC | L | 25.7 | 3 | 5 | 3 | 1 | 2 | 1 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 1 | 4 | 25.0% | -12.0 |
| 2026-03-21 | PHI @ UTA | W | 26.6 | 16 | 5 | 0 | 1 | 2 | 0 | 7 | 12 | 58.3% | 0 | 0 | 0.0% | 2 | 4 | 50.0% | 6.0 |
| 2026-03-19 | PHI @ SAC | W | 20.4 | 8 | 10 | 0 | 2 | 0 | 2 | 2 | 3 | 66.7% | 0 | 0 | 0.0% | 4 | 4 | 100.0% | 18.0 |
| 2026-03-17 | PHI @ DEN | L | 14.8 | 6 | 3 | 1 | 1 | 3 | 1 | 2 | 3 | 66.7% | 0 | 1 | 0.0% | 2 | 2 | 100.0% | -7.0 |
| 2026-03-15 | PHI vs. POR | W | 13.3 | 2 | 6 | 0 | 0 | 1 | 1 | 1 | 5 | 20.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -8.0 |
| 2026-03-14 | PHI vs. BKN | W | 32.8 | 9 | 10 | 0 | 1 | 3 | 2 | 2 | 5 | 40.0% | 0 | 0 | 0.0% | 5 | 5 | 100.0% | 13.0 |
| 2026-03-10 | PHI vs. MEM | W | 15.8 | 4 | 3 | 1 | 1 | 0 | 0 | 2 | 3 | 66.7% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -8.0 |
| 2026-03-09 | PHI @ CLE | L | 26.1 | 8 | 7 | 0 | 0 | 0 | 0 | 4 | 10 | 40.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -13.0 |
| 2026-03-07 | PHI @ ATL | L | 29.1 | 4 | 7 | 3 | 0 | 1 | 1 | 2 | 4 | 50.0% | 0 | 0 | 0.0% | 0 | 2 | 0.0% | 1.0 |
| 2026-03-04 | PHI vs. UTA | W | 28.7 | 12 | 5 | 1 | 1 | 1 | 1 | 6 | 8 | 75.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 5.0 |
| 2026-03-03 | PHI vs. SAS | L | 22.1 | 6 | 6 | 2 | 0 | 0 | 2 | 2 | 3 | 66.7% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | -18.0 |
| 2026-03-01 | PHI @ BOS | L | 15.9 | 5 | 4 | 1 | 0 | 1 | 0 | 2 | 4 | 50.0% | 0 | 0 | 0.0% | 1 | 2 | 50.0% | -7.0 |
| 2026-02-26 | PHI vs. MIA | W | 14.8 | 4 | 3 | 0 | 0 | 1 | 2 | 2 | 2 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 4.0 |
| 2026-02-24 | PHI @ IND | W | 14.9 | 6 | 5 | 3 | 2 | 1 | 1 | 3 | 3 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 27.0 |
| 2026-02-22 | PHI @ MIN | W | 19.9 | 8 | 5 | 2 | 0 | 0 | 0 | 4 | 4 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 20.0 |
| 2026-02-21 | PHI @ NOP | L | 21.4 | 4 | 10 | 1 | 0 | 1 | 0 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 2.0 |
| 2026-02-19 | PHI vs. ATL | L | 19.7 | 9 | 7 | 0 | 0 | 4 | 1 | 3 | 5 | 60.0% | 0 | 0 | 0.0% | 3 | 4 | 75.0% | -3.0 |
| 2026-02-11 | PHI vs. NYK | L | 22.7 | 6 | 5 | 0 | 2 | 0 | 2 | 2 | 4 | 50.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | -24.0 |
| 2026-02-09 | PHI @ POR | L | 17.5 | 7 | 1 | 0 | 0 | 0 | 0 | 2 | 3 | 66.7% | 0 | 0 | 0.0% | 3 | 3 | 100.0% | -14.0 |
| 2026-02-07 | PHI @ PHX | W | 14.8 | 4 | 5 | 0 | 1 | 1 | 2 | 2 | 3 | 66.7% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 19.0 |
| 2026-02-05 | PHI @ LAL | L | 11.0 | 2 | 1 | 0 | 0 | 0 | 0 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -17.0 |
| 2026-02-03 | PHI @ GSW | W | 16.0 | 11 | 7 | 0 | 1 | 0 | 0 | 5 | 6 | 83.3% | 0 | 0 | 0.0% | 1 | 2 | 50.0% | 10.0 |
| 2026-02-02 | PHI @ LAC | W | 15.8 | 6 | 3 | 1 | 0 | 2 | 0 | 3 | 4 | 75.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 13.0 |
| 2026-01-31 | PHI vs. NOP | W | 12.8 | 3 | 6 | 0 | 0 | 2 | 2 | 1 | 5 | 20.0% | 0 | 0 | 0.0% | 1 | 2 | 50.0% | -2.0 |
| 2026-01-29 | PHI vs. SAC | W | 8.3 | 0 | 2 | 0 | 0 | 2 | 0 | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -3.0 |
| 2026-01-27 | PHI vs. MIL | W | 17.4 | 6 | 8 | 0 | 0 | 2 | 0 | 3 | 6 | 50.0% | 0 | 0 | 0.0% | 0 | 1 | 0.0% | 10.0 |
| 2026-01-26 | PHI @ CHA | L | 16.5 | 2 | 2 | 0 | 2 | 0 | 1 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -26.0 |
| 2026-01-24 | PHI vs. NYK | L | 11.6 | 2 | 1 | 0 | 0 | 1 | 1 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0.0 |
| 2026-01-22 | PHI vs. HOU | W | 7.4 | 1 | 3 | 1 | 0 | 0 | 1 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 1 | 2 | 50.0% | -15.0 |
| 2026-01-20 | PHI vs. PHX | L | 26.3 | 11 | 10 | 0 | 0 | 2 | 4 | 4 | 5 | 80.0% | 0 | 0 | 0.0% | 3 | 4 | 75.0% | -4.0 |
| 2026-01-19 | PHI vs. IND | W | 14.7 | 2 | 4 | 0 | 1 | 2 | 0 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 6.0 |
| 2026-01-16 | PHI vs. CLE | L | 14.9 | 4 | 4 | 0 | 0 | 3 | 1 | 2 | 3 | 66.7% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -11.0 |
| 2026-01-14 | PHI vs. CLE | L | 11.1 | 6 | 2 | 0 | 1 | 0 | 1 | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 4 | 4 | 100.0% | 0.0 |
| 2026-01-12 | PHI @ TOR | W | 12.3 | 0 | 2 | 0 | 0 | 1 | 1 | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 1.0 |
| 2026-01-11 | PHI @ TOR | L | 32.8 | 9 | 5 | 0 | 0 | 2 | 1 | 3 | 4 | 75.0% | 0 | 0 | 0.0% | 3 | 4 | 75.0% | 12.0 |
| 2026-01-07 | PHI vs. WAS | W | 10.2 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -21.0 |
| 2026-01-05 | PHI vs. DEN | L | 22.9 | 8 | 6 | 2 | 0 | 1 | 1 | 4 | 5 | 80.0% | 0 | 0 | 0.0% | 0 | 1 | 0.0% | -6.0 |
| 2026-01-03 | PHI @ NYK | W | 18.3 | 2 | 6 | 0 | 1 | 0 | 0 | 1 | 3 | 33.3% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 4.0 |
| 2026-01-01 | PHI @ DAL | W | 7.3 | 2 | 4 | 0 | 0 | 0 | 0 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 7.0 |
| 2025-12-30 | PHI @ MEM | W | 25.6 | 4 | 6 | 2 | 1 | 2 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 4 | 6 | 66.7% | 3.0 |
| 2025-12-28 | PHI @ OKC | L | 28.4 | 11 | 8 | 1 | 0 | 4 | 2 | 3 | 4 | 75.0% | 0 | 0 | 0.0% | 5 | 6 | 83.3% | -10.0 |
| 2025-12-26 | PHI @ CHI | L | 7.5 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0.0% | 0 | 1 | 0.0% | 1 | 2 | 50.0% | 0.0 |
| 2025-12-23 | PHI vs. BKN | L | 18.6 | 4 | 1 | 0 | 0 | 0 | 0 | 2 | 2 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 6.0 |
| 2025-12-20 | PHI vs. DAL | W | 24.8 | 10 | 8 | 0 | 1 | 1 | 1 | 2 | 6 | 33.3% | 1 | 1 | 100.0% | 5 | 6 | 83.3% | 17.0 |
| 2025-12-19 | PHI @ NYK | W | 14.8 | 3 | 2 | 0 | 0 | 3 | 1 | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 1 | 2 | 50.0% | -1.0 |
| 2025-12-05 | PHI @ MIL | W | 23.7 | 10 | 6 | 0 | 1 | 0 | 1 | 4 | 7 | 57.1% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 9.0 |
| 2025-12-04 | PHI vs. GSW | W | 6.0 | 2 | 2 | 0 | 0 | 0 | 0 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 0 | 2 | 0.0% | -2.0 |
| 2025-12-02 | PHI vs. WAS | W | 21.7 | 4 | 5 | 0 | 0 | 1 | 0 | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 26.0 |
| 2025-11-30 | PHI vs. ATL | L | 22.0 | 4 | 3 | 0 | 0 | 2 | 2 | 1 | 3 | 33.3% | 0 | 1 | 0.0% | 2 | 2 | 100.0% | 2.0 |
| 2025-11-28 | PHI @ BKN | W | 22.8 | 13 | 6 | 0 | 0 | 3 | 2 | 6 | 7 | 85.7% | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 6.0 |
| 2025-11-14 | PHI @ DET | L | 9.3 | 2 | 5 | 0 | 0 | 1 | 0 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -9.0 |
| 2025-11-11 | PHI vs. BOS | W | 14.5 | 2 | 4 | 0 | 0 | 2 | 0 | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 0 | 2 | 0.0% | -8.0 |
| 2025-11-09 | PHI vs. DET | L | 12.5 | 2 | 4 | 0 | 1 | 3 | 0 | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 8.0 |
| 2025-11-08 | PHI vs. TOR | W | 6.0 | 0 | 2 | 0 | 0 | 1 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -13.0 |
| 2025-11-05 | PHI @ CLE | L | 18.3 | 4 | 4 | 0 | 2 | 0 | 3 | 1 | 3 | 33.3% | 0 | 1 | 0.0% | 2 | 5 | 40.0% | -16.0 |
| 2025-11-04 | PHI @ CHI | L | 22.4 | 2 | 4 | 0 | 0 | 1 | 0 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -3.0 |
| 2025-11-02 | PHI @ BKN | W | 14.3 | 2 | 3 | 0 | 1 | 1 | 0 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -4.0 |
| 2025-10-31 | PHI vs. BOS | L | 11.1 | 2 | 3 | 0 | 0 | 2 | 1 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -10.0 |
| 2025-10-28 | PHI @ WAS | W | 17.5 | 2 | 5 | 0 | 0 | 5 | 1 | 1 | 3 | 33.3% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 5.0 |
| 2025-10-27 | PHI vs. ORL | W | 24.6 | 7 | 4 | 1 | 0 | 3 | 0 | 2 | 3 | 66.7% | 0 | 0 | 0.0% | 3 | 5 | 60.0% | 21.0 |
| 2025-10-25 | PHI vs. CHA | W | 12.0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 1 | 2 | 50.0% | -6.0 |
| 2025-10-22 | PHI @ BOS | W | 14.7 | 0 | 3 | 1 | 0 | 0 | 2 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 4.0 |